HC Deb 20 January 2004 vol 416 c1110W
Mr. Drew

To ask the Secretary of State for Health if he will clarify the National Institute for Clinical Excellence advice on the provision of medicines to those patients diagnosed with osteoporosis. [148276]

Dr. Ladyman

The National Institute for Clinical Excellence (NICE) is consulting on the first draft of a technology appraisal on the use of medicines for the prevention and treatment of osteoporosis and prevention of osteoporotic fractures in postmenopausal women. The document does not constitute NICE's formal guidance on this technology: the recommendations are preliminary and may change after the consultation. The draft document is available on the NICE website at www.nice.org.uk.